| Old Articles: <Older 37071-37080 Newer> |
 |
The Motley Fool June 29, 2009 David Lee Smith |
There's a Shell in Russia's Bed Again Despite getting shoved aside in Sakhalin two years ago, Shell will venture forth again.  |
The Motley Fool June 29, 2009 Rich Smith |
This Just In: Upgrades and Downgrades While everyone else was busy clambering into the bullish bandwagon, analysts at FBR downgraded Dow stalwart Alcoa.  |
The Motley Fool June 29, 2009 Dan Caplinger |
How to Beat Risk Before It Beats You In putting together a lifetime financial plan for your investments, you want to balance the risks you take against the returns you earn. But, figuring out the right way to accomplish that task is easier said than done.  |
The Motley Fool June 29, 2009 David Lee Smith |
A Good Way to Jack Up Your Profits Even with crude prices stalled, there's a lot to recommend Diamond Offshore.  |
The Motley Fool June 29, 2009 Dave Mock |
A Big Upgrade for WellCare Health Plans This bullish call comes from more than just one analyst. More top-performing Motley Fool CAPS members are feeling bullish about WellCare Health Plans.  |
The Motley Fool June 29, 2009 Brian Orelli |
Lantus Results: Reply Hazy, Try Again Later Drugmaker Sanofi's problems become murkier. Investors are relieved that the data is out -- Sanofi is up about 4.5% at the moment -- but it seems prudent to be cautious here.  |
The Motley Fool June 29, 2009 Rick Aristotle Munarriz |
Sirius XM Is Quicker Than You Think Sirius XM's proven ability to remain timely should help with subscriber retention.  |
The Motley Fool June 29, 2009 Anders Bylund |
EMC's Just Not That Into Data Domain Anymore EMC officially stretches its tender offer further. But it's probably just an academic exercise.  |
The Motley Fool June 29, 2009 Dan Caplinger |
Is There Free Money In These Stocks? Sometimes, a bargain price on a stock seems to offer investors free money. If you don't understand the risks involved, though, attractive stocks can burn you.  |
The Motley Fool June 29, 2009 Brian Orelli |
Gilead Says "Pleeeease." EU Says "Well, OK." This appeal actually resulted in an approved drug.  |
| <Older 37071-37080 Newer> Return to current articles. |